
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            In silico prediction of optimal multifactorial intervention in chronic kidney disease - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="15253D468AF26863053D460006D2D27B.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="transmed">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Journal of Translational Medicine">
<meta name="citation_title" content="In silico prediction of optimal multifactorial intervention in chronic kidney disease">
<meta name="citation_author" content="Agnieszka Latosinska">
<meta name="citation_author_institution" content="Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany">
<meta name="citation_author" content="Ioanna K Mina">
<meta name="citation_author_institution" content="Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany">
<meta name="citation_author_institution" content="Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Aachen, Germany">
<meta name="citation_author" content="Thi Minh Nghia Nguyen">
<meta name="citation_author_institution" content="Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany">
<meta name="citation_author" content="Igor Golovko">
<meta name="citation_author_institution" content="Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany">
<meta name="citation_author" content="Felix Keller">
<meta name="citation_author_institution" content="Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria">
<meta name="citation_author" content="Gert Mayer">
<meta name="citation_author_institution" content="Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria">
<meta name="citation_author" content="Peter Rossing">
<meta name="citation_author_institution" content="Steno Diabetes Center Copenhagen, Herlev, Denmark">
<meta name="citation_author_institution" content="Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark">
<meta name="citation_author" content="Jan A Staessen">
<meta name="citation_author_institution" content="Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechlin, Belgium">
<meta name="citation_author" content="Christian Delles">
<meta name="citation_author_institution" content="School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK">
<meta name="citation_author" content="Joachim Beige">
<meta name="citation_author_institution" content="Division of Nephrology and KfH Renal Unit, Hospital St Georg, Leipzig, Germany">
<meta name="citation_author_institution" content="Martin-Luther University Halle, Wittenberg, Germany">
<meta name="citation_author" content="Griet Glorieux">
<meta name="citation_author_institution" content="Department of Internal Medicine and Paediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium">
<meta name="citation_author" content="Andrew L Clark">
<meta name="citation_author_institution" content="Hull and East Yorkshire NHS Hospitals Trust, Castle Hill Hospital, Cottingham, UK">
<meta name="citation_author" content="Joost P Schanstra">
<meta name="citation_author_institution" content="Institute of Cardiovascular and Metabolic Disease, Institut National de La Santé Et de La Recherche Médicale (INSERM), U1297 Toulouse, France">
<meta name="citation_author_institution" content="Université de Toulouse, Toulouse, France">
<meta name="citation_author" content="Antonia Vlahou">
<meta name="citation_author_institution" content="Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece">
<meta name="citation_author" content="Karlheinz Peter">
<meta name="citation_author_institution" content="Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, VIC Australia">
<meta name="citation_author_institution" content="Department of Physiology, Anatomy, Microbiology, La Trobe University, Melbourne, VIC Australia">
<meta name="citation_author_institution" content="Department of Medicine and Immunology, Monash University, Melbourne, VIC Australia">
<meta name="citation_author_institution" content="Department of Cardiometabolic Health, University of Melbourne, VIC, Australia">
<meta name="citation_author" content="Ivan Rychlík">
<meta name="citation_author_institution" content="Department of Internal Medicine, Third Faculty of Medicine, Charles University, and University Hospital Královské Vinohrady, Prague, Czech Republic">
<meta name="citation_author" content="Alberto Ortiz">
<meta name="citation_author_institution" content="Instituto de Investigación Sanitaria de La Fundación Jiménez Díaz (IIS-FJD) UAM, Madrid, Spain">
<meta name="citation_author" content="Archie Campbell">
<meta name="citation_author_institution" content="Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK">
<meta name="citation_author" content="Harald Rupprecht">
<meta name="citation_author_institution" content="Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany">
<meta name="citation_author_institution" content="Department of Nephrology, Medizincampus Oberfranken, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany">
<meta name="citation_author_institution" content="Kuratorium for Dialysis and Transplantation (KfH) Bayreuth, Bayreuth, Germany">
<meta name="citation_author" content="Frederik Persson">
<meta name="citation_author_institution" content="Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark">
<meta name="citation_author" content="Harald Mischak">
<meta name="citation_author_institution" content="Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany">
<meta name="citation_author_institution" content="School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK">
<meta name="citation_author" content="Justyna Siwy">
<meta name="citation_author_institution" content="Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany">
<meta name="citation_publication_date" content="2025 Aug 21">
<meta name="citation_volume" content="23">
<meta name="citation_firstpage" content="943">
<meta name="citation_doi" content="10.1186/s12967-025-06977-3">
<meta name="citation_pmid" content="40842026">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/pdf/12967_2025_Article_6977.pdf">
<meta name="description" content="Chronic kidney disease (CKD) contributes to global morbidity and mortality. Early, targeted intervention can help mitigate its impact. CK273 is a urinary peptide classifier previously validated in a prospective clinical trial for the early detection ...">
<meta name="og:title" content="In silico prediction of optimal multifactorial intervention in chronic kidney disease">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Chronic kidney disease (CKD) contributes to global morbidity and mortality. Early, targeted intervention can help mitigate its impact. CK273 is a urinary peptide classifier previously validated in a prospective clinical trial for the early detection ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372250">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1186/s12967-025-06977-3"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/12967_2025_Article_6977.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372250%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372250/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372250/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-transmed.png" alt="Journal of Translational Medicine logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Journal of Translational Medicine" title="Link to Journal of Translational Medicine" shape="default" href="https://translational-medicine.biomedcentral.com/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">J Transl Med</button></div>. 2025 Aug 21;23:943. doi: <a href="https://doi.org/10.1186/s12967-025-06977-3" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1186/s12967-025-06977-3</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22J%20Transl%20Med%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22J%20Transl%20Med%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22J%20Transl%20Med%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22J%20Transl%20Med%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>In silico prediction of optimal multifactorial intervention in chronic kidney disease</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Latosinska%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Agnieszka Latosinska</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Agnieszka Latosinska</span></h3>
<div class="p">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Latosinska%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Agnieszka Latosinska</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mina%20IK%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Ioanna K Mina</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Ioanna K Mina</span></h3>
<div class="p">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div class="p">
<sup>2</sup>Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Aachen, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mina%20IK%22%5BAuthor%5D" class="usa-link"><span class="name western">Ioanna K Mina</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nguyen%20TMN%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Thi Minh Nghia Nguyen</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Thi Minh Nghia Nguyen</span></h3>
<div class="p">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Nguyen%20TMN%22%5BAuthor%5D" class="usa-link"><span class="name western">Thi Minh Nghia Nguyen</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Golovko%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Igor Golovko</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Igor Golovko</span></h3>
<div class="p">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Golovko%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Igor Golovko</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Keller%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Felix Keller</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Felix Keller</span></h3>
<div class="p">
<sup>3</sup>Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Keller%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Felix Keller</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mayer%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Gert Mayer</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Gert Mayer</span></h3>
<div class="p">
<sup>3</sup>Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mayer%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Gert Mayer</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rossing%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Peter Rossing</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Peter Rossing</span></h3>
<div class="p">
<sup>4</sup>Steno Diabetes Center Copenhagen, Herlev, Denmark </div>
<div class="p">
<sup>5</sup>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rossing%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Peter Rossing</span></a>
</div>
</div>
<sup>4,</sup><sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Staessen%20JA%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Jan A Staessen</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Jan A Staessen</span></h3>
<div class="p">
<sup>6</sup>Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechlin, Belgium </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Staessen%20JA%22%5BAuthor%5D" class="usa-link"><span class="name western">Jan A Staessen</span></a>
</div>
</div>
<sup>6</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delles%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Christian Delles</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Christian Delles</span></h3>
<div class="p">
<sup>7</sup>School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Delles%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christian Delles</span></a>
</div>
</div>
<sup>7</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Beige%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Joachim Beige</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Joachim Beige</span></h3>
<div class="p">
<sup>8</sup>Division of Nephrology and KfH Renal Unit, Hospital St Georg, Leipzig, Germany </div>
<div class="p">
<sup>9</sup>Martin-Luther University Halle, Wittenberg, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Beige%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Joachim Beige</span></a>
</div>
</div>
<sup>8,</sup><sup>9</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Glorieux%20G%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Griet Glorieux</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Griet Glorieux</span></h3>
<div class="p">
<sup>10</sup>Department of Internal Medicine and Paediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Glorieux%20G%22%5BAuthor%5D" class="usa-link"><span class="name western">Griet Glorieux</span></a>
</div>
</div>
<sup>10</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clark%20AL%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Andrew L Clark</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Andrew L Clark</span></h3>
<div class="p">
<sup>11</sup>Hull and East Yorkshire NHS Hospitals Trust, Castle Hill Hospital, Cottingham, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Clark%20AL%22%5BAuthor%5D" class="usa-link"><span class="name western">Andrew L Clark</span></a>
</div>
</div>
<sup>11</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schanstra%20JP%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Joost P Schanstra</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Joost P Schanstra</span></h3>
<div class="p">
<sup>12</sup>Institute of Cardiovascular and Metabolic Disease, Institut National de La Santé Et de La Recherche Médicale (INSERM), U1297 Toulouse, France </div>
<div class="p">
<sup>13</sup>Université de Toulouse, Toulouse, France </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schanstra%20JP%22%5BAuthor%5D" class="usa-link"><span class="name western">Joost P Schanstra</span></a>
</div>
</div>
<sup>12,</sup><sup>13</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vlahou%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Antonia Vlahou</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Antonia Vlahou</span></h3>
<div class="p">
<sup>14</sup>Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Vlahou%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Antonia Vlahou</span></a>
</div>
</div>
<sup>14</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peter%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id15"><span class="name western">Karlheinz Peter</span></a><div hidden="hidden" id="id15">
<h3><span class="name western">Karlheinz Peter</span></h3>
<div class="p">
<sup>15</sup>Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, VIC Australia </div>
<div class="p">
<sup>16</sup>Department of Physiology, Anatomy, Microbiology, La Trobe University, Melbourne, VIC Australia </div>
<div class="p">
<sup>17</sup>Department of Medicine and Immunology, Monash University, Melbourne, VIC Australia </div>
<div class="p">
<sup>18</sup>Department of Cardiometabolic Health, University of Melbourne, VIC, Australia </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Peter%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Karlheinz Peter</span></a>
</div>
</div>
<sup>15,</sup><sup>16,</sup><sup>17,</sup><sup>18</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rychl%C3%ADk%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id16"><span class="name western">Ivan Rychlík</span></a><div hidden="hidden" id="id16">
<h3><span class="name western">Ivan Rychlík</span></h3>
<div class="p">
<sup>19</sup>Department of Internal Medicine, Third Faculty of Medicine, Charles University, and University Hospital Královské Vinohrady, Prague, Czech Republic </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rychl%C3%ADk%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Ivan Rychlík</span></a>
</div>
</div>
<sup>19</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ortiz%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id17"><span class="name western">Alberto Ortiz</span></a><div hidden="hidden" id="id17">
<h3><span class="name western">Alberto Ortiz</span></h3>
<div class="p">
<sup>20</sup>Instituto de Investigación Sanitaria de La Fundación Jiménez Díaz (IIS-FJD) UAM, Madrid, Spain </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Ortiz%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alberto Ortiz</span></a>
</div>
</div>
<sup>20</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Campbell%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id18"><span class="name western">Archie Campbell</span></a><div hidden="hidden" id="id18">
<h3><span class="name western">Archie Campbell</span></h3>
<div class="p">
<sup>21</sup>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Campbell%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Archie Campbell</span></a>
</div>
</div>
<sup>21</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rupprecht%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id19"><span class="name western">Harald Rupprecht</span></a><div hidden="hidden" id="id19">
<h3><span class="name western">Harald Rupprecht</span></h3>
<div class="p">
<sup>22</sup>Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany </div>
<div class="p">
<sup>23</sup>Department of Nephrology, Medizincampus Oberfranken, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany </div>
<div class="p">
<sup>24</sup>Kuratorium for Dialysis and Transplantation (KfH) Bayreuth, Bayreuth, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Rupprecht%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Harald Rupprecht</span></a>
</div>
</div>
<sup>22,</sup><sup>23,</sup><sup>24</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Persson%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id20"><span class="name western">Frederik Persson</span></a><div hidden="hidden" id="id20">
<h3><span class="name western">Frederik Persson</span></h3>
<div class="p">
<sup>5</sup>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Persson%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Frederik Persson</span></a>
</div>
</div>
<sup>5</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mischak%20H%22%5BAuthor%5D" class="usa-link" aria-describedby="id21"><span class="name western">Harald Mischak</span></a><div hidden="hidden" id="id21">
<h3><span class="name western">Harald Mischak</span></h3>
<div class="p">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div class="p">
<sup>7</sup>School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Mischak%20H%22%5BAuthor%5D" class="usa-link"><span class="name western">Harald Mischak</span></a>
</div>
</div>
<sup>1,</sup><sup>7,</sup><sup>✉</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Siwy%20J%22%5BAuthor%5D" class="usa-link" aria-describedby="id22"><span class="name western">Justyna Siwy</span></a><div hidden="hidden" id="id22">
<h3><span class="name western">Justyna Siwy</span></h3>
<div class="p">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Siwy%20J%22%5BAuthor%5D" class="usa-link"><span class="name western">Justyna Siwy</span></a>
</div>
</div>
<sup>1</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="Aff1">
<sup>1</sup>Mosaiques Diagnostics GmbH, Rotenburger Straße 20, 30659 Hannover, Germany </div>
<div id="Aff2">
<sup>2</sup>Institute for Molecular Cardiovascular Research, University Hospital RWTH Aachen, Aachen, Germany </div>
<div id="Aff3">
<sup>3</sup>Department of Internal Medicine IV (Nephrology and Hypertension), Medical University Innsbruck, Innsbruck, Austria </div>
<div id="Aff4">
<sup>4</sup>Steno Diabetes Center Copenhagen, Herlev, Denmark </div>
<div id="Aff5">
<sup>5</sup>Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark </div>
<div id="Aff6">
<sup>6</sup>Non-Profit Research Institute Alliance for the Promotion of Preventive Medicine, Mechlin, Belgium </div>
<div id="Aff7">
<sup>7</sup>School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK </div>
<div id="Aff8">
<sup>8</sup>Division of Nephrology and KfH Renal Unit, Hospital St Georg, Leipzig, Germany </div>
<div id="Aff9">
<sup>9</sup>Martin-Luther University Halle, Wittenberg, Germany </div>
<div id="Aff10">
<sup>10</sup>Department of Internal Medicine and Paediatrics, Nephrology Section, Ghent University Hospital, Ghent, Belgium </div>
<div id="Aff11">
<sup>11</sup>Hull and East Yorkshire NHS Hospitals Trust, Castle Hill Hospital, Cottingham, UK </div>
<div id="Aff12">
<sup>12</sup>Institute of Cardiovascular and Metabolic Disease, Institut National de La Santé Et de La Recherche Médicale (INSERM), U1297 Toulouse, France </div>
<div id="Aff13">
<sup>13</sup>Université de Toulouse, Toulouse, France </div>
<div id="Aff14">
<sup>14</sup>Centre of Systems Biology, Biomedical Research Foundation of the Academy of Athens, Athens, Greece </div>
<div id="Aff15">
<sup>15</sup>Atherothrombosis and Vascular Biology Program, Baker Heart and Diabetes Institute, Melbourne, VIC Australia </div>
<div id="Aff16">
<sup>16</sup>Department of Physiology, Anatomy, Microbiology, La Trobe University, Melbourne, VIC Australia </div>
<div id="Aff17">
<sup>17</sup>Department of Medicine and Immunology, Monash University, Melbourne, VIC Australia </div>
<div id="Aff18">
<sup>18</sup>Department of Cardiometabolic Health, University of Melbourne, VIC, Australia </div>
<div id="Aff19">
<sup>19</sup>Department of Internal Medicine, Third Faculty of Medicine, Charles University, and University Hospital Královské Vinohrady, Prague, Czech Republic </div>
<div id="Aff20">
<sup>20</sup>Instituto de Investigación Sanitaria de La Fundación Jiménez Díaz (IIS-FJD) UAM, Madrid, Spain </div>
<div id="Aff21">
<sup>21</sup>Centre for Genomic and Experimental Medicine, Institute of Genetics and Cancer, University of Edinburgh, Edinburgh, UK </div>
<div id="Aff22">
<sup>22</sup>Department of Nephrology, Angiology and Rheumatology, Klinikum Bayreuth GmbH, Bayreuth, Germany </div>
<div id="Aff23">
<sup>23</sup>Department of Nephrology, Medizincampus Oberfranken, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany </div>
<div id="Aff24">
<sup>24</sup>Kuratorium for Dialysis and Transplantation (KfH) Bayreuth, Bayreuth, Germany </div>
<div class="author-notes p"><div class="fn" id="_fncrsp93pmc__">
<sup>✉</sup><p class="display-inline">Corresponding author.</p>
</div></div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2025 Jul 31; Accepted 2025 Aug 5; Collection date 2025.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© The Author(s) 2025</div>
<p><strong>Open Access</strong> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://creativecommons.org/licenses/by/4.0/</a>.</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372250  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40842026/" class="usa-link">40842026</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="Abs1"><h2>Abstract</h2>
<section id="sec1"><h3 class="pmc_sec_title">Background</h3>
<p id="Par1">Chronic kidney disease (CKD) contributes to global morbidity and mortality. Early, targeted intervention can help mitigate its impact. CK273 is a urinary peptide classifier previously validated in a prospective clinical trial for the early detection of nephropathy. We hypothesized that drug-induced molecular changes in the urinary peptidome could be predicted in silico and guide selecting interventions for individual patients.</p></section><section id="sec2"><h3 class="pmc_sec_title">Methods</h3>
<p id="Par2">The efficacy of the urinary peptidomic classifier CKD273 in predicting major adverse kidney events (≥ 40% decline in estimated glomerular filtration rate or kidney failure -median follow-up: 1.50 (95%CI 0.35, 5.0) years), was confirmed in a retrospective cohort of 935 participants. In silico prediction of treatment effects from four drug-based interventions (Mineralocorticoid receptor antagonist, Sodium-glucose co-transporter 2 inhibitor, Glucagon-like peptide-1 receptor agonist, and Angiotensin receptor blocker), dietary intervention (olive oil), and exercise was performed based on: a) individual baseline urinary peptide profiles, and b) previously defined fold changes in peptide abundance after treatment in clinical trials. Following recalibration to align with outcomes of these trials, CKD273 scores were calculated for each patient after in silico treatment. For combination treatments, the effects of multiple interventions were combined.</p></section><section id="sec3"><h3 class="pmc_sec_title">Results</h3>
<p id="Par3">Simulated interventions demonstrated a significant reduction in median CKD273 scores, from 0.57 (IQR: 0.19–0.81) before to 0.039 (IQR: −0.192–0.363) after the most beneficial intervention (paired Wilcoxon test, <em>P</em> &lt; 0.0001). The combination of all available treatments was not the most frequently predicted optimal intervention. Patients with higher baseline CKD273 scores required more complex intervention combinations to achieve the greatest score reduction.</p></section><section id="sec4"><h3 class="pmc_sec_title">Conclusions</h3>
<p id="Par4">This study supports the feasibility of in silico predicting effects of therapeutic interventions on CKD progression. By identifying the most beneficial treatment combinations for individual patients, this approach paves the way for precision medicine trials in CKD. A prospective study is currently being planned to validate the in silico-guided intervention approach and determine its exact benefits on patient-relevant outcomes.</p></section><section id="sec5"><h3 class="pmc_sec_title">Supplementary Information</h3>
<p>The online version contains supplementary material available at 10.1186/s12967-025-06977-3.</p></section><section id="kwd-group1" lang="en" class="kwd-group"><p><strong>Keywords:</strong> Chronic kidney disease, Clinical proteomics, Drug response prediction, Optimizing intervention, Urine peptides</p></section></section><section id="Sec1"><h2 class="pmc_sec_title">Background</h2>
<p id="Par17">The development of multiple different treatment options for chronic kidney disease (CKD) has resulted in a major change of patient management. In the past, treatment was primarily focused on managing the underlying risk factors, such as hypertension and diabetes, through the use of antihypertensive and anti-diabetic therapies. Angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) were commonly prescribed to control blood pressure, one key driver of CKD progression [<a href="#CR1" class="usa-link" aria-describedby="CR1">1</a>]. These treatments, while beneficial in slowing disease progression in some cases, are not addressing the complex pathophysiology of kidney damage. Recently, multiple novel drug classes were introduced, all demonstrating benefit in reducing progression in CKD. Sodium-glucose co-transporter 2 inhibitors (SGLT2i), initially developed for the management of type 2 diabetes, reduce albuminuria, protect against decline in kidney function, and improve cardiovascular outcomes in patients with CKD, both with and without diabetes [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>–<a href="#CR4" class="usa-link" aria-describedby="CR4">4</a>]. These effects are thought to be mediated by mechanisms such as improved glomerular hemodynamics, reduced inflammation, and enhanced tubuloglomerular feedback [<a href="#CR5" class="usa-link" aria-describedby="CR5">5</a>]. Another recent development is the use of the non-steroidal mineralocorticoid receptor antagonist (MRA), finerenone, [<a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>]. which targets the mineralocorticoid receptor more selectively than traditional MRAs such as spironolactone. MRAs may help counteract the fibrosis and inflammation seen in CKD progression [<a href="#CR7" class="usa-link" aria-describedby="CR7">7</a>]. Glucagon-like peptide-1 (GLP-1) receptor agonists, such as semaglutide, reduce albuminuria and improve kidney outcomes, particularly in obese patients with diabetes [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. Their effects are thought to be due to a combination of metabolic benefits, especially weight loss and improved insulin sensitivity. Endothelin-1 receptor antagonists are another class of drugs under investigation for CKD treatment. Endothelin-1 is a potent vasoconstrictor that contributes to kidney fibrosis and glomerular injury. Blocking the endothelin receptor, endothelin-1 antagonists, in combination with ARBs, may reduce kidney injury and progression in various forms of CKD [<a href="#CR9" class="usa-link" aria-describedby="CR9">9</a>]. Initial findings suggest that endothelin-1 antagonists could offer additional benefits for patients with specific CKD phenotypes. Additional evidence also supports non-drug interventions such as dietary and lifestyle changes in the management of CKD [<a href="#CR10" class="usa-link" aria-describedby="CR10">10</a>, <a href="#CR11" class="usa-link" aria-describedby="CR11">11</a>].</p>
<p id="Par18">These multiple treatment options highlight the need for specific, personalized treatment guidelines for CKD. Personalized treatment based on specific molecular features is by now routine in oncology, [<a href="#CR12" class="usa-link" aria-describedby="CR12">12</a>]. with treatment targeting specific molecular changes. In contrast, due in part to the absence of a specific mutation causing CKD (with some rare exceptions like e.g. autosomal dominant polycystic kidney disease or Alport syndrome), personalized interventions are generally not implemented in nephrology. While pharmaceutical companies, in their own interest, often promote a “one-size-fits-all” approach, advocating the use of their respective drug in every patient, this strategy leads to an increased risk of adverse drug interactions, higher healthcare costs (e.g. yearly costs of Sparsentan, for the treatment of primary immunoglobulin A nephropathy, exceed 50,000 €, [<a href="#CR13" class="usa-link" aria-describedby="CR13">13</a>]), and potential side effects, especially in a population already at high risk of comorbidities. Moreover, clinical evidence supporting the combined use of all these agents is generally moderate, inconclusive or non-existent. For example, studies examining the combination of GLP-1 receptor agonists with SGLT2i have failed to demonstrate an added benefit in kidney protection, [<a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>]. raising questions about the optimal use of combination therapies in CKD management.</p>
<p id="Par19">We have developed a urine peptide-based classifier, CKD273, which allows for early detection of CKD and provides prognostic information regarding disease progression [<a href="#CR14" class="usa-link" aria-describedby="CR14">14</a>, <a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. This classifier uses peptidomic analysis of urine to capture molecular signatures of kidney dysfunction and predict outcomes. In parallel, we have investigated how various therapeutic interventions affect the urine peptidome [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>]. Using computational models, prediction of the effects of individual treatments was demonstrated as a feasible approach [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]. The data generated from these studies indicate substantial variability in treatment responses in individuals, underscoring the need for personalized treatment strategies. What works best for one patient may not be effective in another, even if their clinical phenotype is overall quite similar.</p>
<p id="Par20">Here we describe a predictive framework based on CKD273 scoring that enables clinicians to design personalized treatment regimens that maximize therapeutic efficacy while minimizing the risk of adverse effects (Fig. <a href="#Fig1" class="usa-link">1</a>). We hypothesized that molecular changes in the urinary peptidome can predict the most beneficial combination of therapeutic interventions for individual patients. To test this hypothesis, we investigated the in silico molecular effects of six different therapeutic interventions, in all possible combinations, on the urine peptidome to identify the optimal treatment for each patient.</p>
<figure class="fig xbox font-sm" id="Fig1"><h3 class="obj_head">Fig. 1.</h3>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372250_12967_2025_6977_Fig1_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/278b/12372250/69d2bab80be1/12967_2025_6977_Fig1_HTML.jpg" loading="lazy" id="MO1" height="423" width="783" alt="Fig. 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Overview of the approach. Different types of intervention were applied in silico on urinary peptidomics data to predict the impact of treatment, with the extent of the impact being calibrated to fit the observed effect in large randomized trials. The personalized optimal combination of interventions was determined in 935 patients, based on the impact on CKD273. The results indicate that guiding personalized treatment based on urine peptide data is possible and may substantially improve patient management</p></figcaption></figure></section><section id="Sec2"><h2 class="pmc_sec_title">Methods</h2>
<section id="Sec3"><h3 class="pmc_sec_title">Study participants and study design</h3>
<p id="Par21">This study includes datasets from 935 patients from previous studies on diabetes and CKD: PRIORITY, DIRECT, PREDICTIONS, SUNmacro, and CACTI. All datasets have been generated using the same analytical platform, capillary electrophoresis coupled to mass spectrometry, and processed using a consistent data processing pipeline to ensure comparability [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR23" class="usa-link" aria-describedby="CR23">23</a>]. Specifically, following data acquisition, peptide mass, migration time, and signal intensity were calibrated using internal urinary standard peptides [<a href="#CR24" class="usa-link" aria-describedby="CR24">24</a>]., thus minimizing batch-related peptide variation [<a href="#CR22" class="usa-link" aria-describedby="CR22">22</a>, <a href="#CR25" class="usa-link" aria-describedby="CR25">25</a>]. Previous studies have shown that the utilised pre-processing approach does not affect the predictive performance of the CKD273 model [<a href="#CR26" class="usa-link" aria-describedby="CR26">26</a>, <a href="#CR27" class="usa-link" aria-describedby="CR27">27</a>]. Detailed information on the designs and the methods used in these studies are available in previous publications [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>, <a href="#CR28" class="usa-link" aria-describedby="CR28">28</a>–<a href="#CR31" class="usa-link" aria-describedby="CR31">31</a>]. Inclusion criteria were availability of relevant demographic and clinical variables including age, sex, body mass index, blood pressure, estimated glomerular filtration rate (eGFR, calculated using the CKD Epidemiology Collaboration, CKD-EPI, 2009 formula), increased risk of CKD based on CKD273 scoring &gt; 0 at the time of the baseline assessment, and availability of follow-up information (eGFR or kidney failure at follow-up). The endpoint was major adverse kidney event (MAKE), defined as a decline of ≥ 40% in eGFR values during follow-up or kidney failure. The study was conducted according to the guidelines of the Declaration of Helsinki. All datasets were fully anonymized and from previous studies. The ethics committee of the Hannover Medical School Germany waived ethical approval under the reference number 3116–2016 for all studies involving re-use of data from anonymized urine samples.</p></section><section id="Sec4"><h3 class="pmc_sec_title">Peptide-based classifiers and prediction of events</h3>
<p id="Par22">The previously developed classifier CKD273 was used for prediction of CKD events and assessment of the impact of different interventions and their combinations. The scores for the classifier were predicted by a support vector machine (SVM) algorithm, integrated into the MosaDiag software, [<a href="#CR32" class="usa-link" aria-describedby="CR32">32</a>] in which the levels of 273 CKD biomarkers detected in the urine of individual patients are compared to their respective levels in CKD. Sample classification was conducted at baseline and after in silico intervention. All statistical tests were performed in MedCalc version 12—© 1993–2013 MedCalc Software.</p></section><section id="Sec5"><h3 class="pmc_sec_title">In-silico impact of intervention</h3>
<p id="Par23">We assessed the impact on urinary peptidomic profiles of four different drug-based interventions (MRAs, SGLT2i, GLP1 receptor agonists, and ARBs); one dietary intervention (olive oil); and one lifestyle intervention, exercise. The data on the treatment induced impact were generated in previous studies either published [<a href="#CR16" class="usa-link" aria-describedby="CR16">16</a>–<a href="#CR20" class="usa-link" aria-describedby="CR20">20</a>, <a href="#CR33" class="usa-link" aria-describedby="CR33">33</a>]. or unpublished (exercise). Treatment effect on peptide abundance was quantified by the fold changes, given in Supplementary Table S1. Fold changes were calculated by dividing the average peptide abundance after treatment by the average peptide abundance before treatment (representing a result of the intervention). Missing abundance values, in general the result of the signal below detection limit, were replaced by zero. Since the follow-up after treatment was in the range of 6 weeks to 9 months, but in general not until MAKE occurred and to limit overestimation of the treatment effect, the applied fold-changes were recalibrated per treatment, ensuring that the effect on MAKE was within the range observed in the respective randomized controlled trials [<a href="#CR2" class="usa-link" aria-describedby="CR2">2</a>, <a href="#CR6" class="usa-link" aria-describedby="CR6">6</a>, <a href="#CR8" class="usa-link" aria-describedby="CR8">8</a>, <a href="#CR34" class="usa-link" aria-describedby="CR34">34</a>]. Specifically, for each treatment, we calculated the ratio between the observed effect in the trial (percentage reduction in time to MAKE) and the predicted effect from our model (percentage reduction in time to 50% MAKE risk). This ratio was then used as a correction factor and applied to adjust the fold changes for each peptide. To simulate the effect of intervention, these re-calibrated fold changes were then applied to multiply the intensities of the respective peptides in each patient, and the predictor (CKD273) scores were re-calculated. When applying a combination of different interventions, similar principle was followed, with the effects combined (via multiplication of all relevant fold changes) (Fig. <a href="#Fig2" class="usa-link">2</a>).</p>
<figure class="fig xbox font-sm" id="Fig2"><h4 class="obj_head">Fig. 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372250_12967_2025_6977_Fig2_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/278b/12372250/736d0d382a44/12967_2025_6977_Fig2_HTML.jpg" loading="lazy" id="MO2" height="329" width="784" alt="Fig. 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Graphical depiction of the study outline. First, urinary peptide data are acquired from patients (Step 1), which then undergo in silico simulated treatment using single (Step 2) or multiple (Step 3) interventions to predict the impact of interventions on individual urinary peptides. In silico predictions are based on past experience with patients that had urinary peptide assessments prior to and after initiation of treatments in clinical studies. In the last step the optimal intervention, resulting in the maximal in silico lowering of the risk (lowest urinary CKD273 peptidomic classifier score), is chosen</p></figcaption></figure></section><section id="Sec6"><h3 class="pmc_sec_title">Transformation of the CKD273 biomarker score into risk of MAKE</h3>
<p id="Par24">To make CKD risk prediction more tangible and link it to a measure of risk of MAKE, the CKD273 score was transformed into the incidence rate of MAKE per 100 person-years (based on the data available from [<a href="#CR21" class="usa-link" aria-describedby="CR21">21</a>]). For each CKD273 score, the incidence rate per 100 person-years was calculated as follows: 100 subjects with the closest CKD273 scores were selected for each target score, comprised of 50 individuals with scores above and 50 with scores below the target score value. Subsequently, for each subset of 100 subjects the sum of observation times was divided by the observed number of subjects experiencing a MAKE, resulting in the average predicted time until MAKE. Assuming linear development, by dividing this value by 2, the expected time to a 50% risk of MAKE in a cohort with a specific CKD273 score was derived (Supplementary Table S2).</p>
<p id="Par25">The relationship between the CKD273 score and the estimated time to a 50% risk of MAKE was then assessed using regression analysis to establish the following association: Log “Days to 50% risk of MAKE” = 4.1446–0.9498*CKD273 score. The derived formula was subsequently used to transform both original CKD273 scores and scores modified after in silico interventions.</p></section></section><section id="Sec7"><h2 class="pmc_sec_title">Results</h2>
<section id="Sec8"><h3 class="pmc_sec_title">Cohort characteristics</h3>
<p id="Par26">Based on the applied criteria, 935 datasets were retrieved, corresponding to 935 individuals. The subjects were predominantly male (73%), diabetic (97.8%) and obese (median body mass index (BMI): 30 kg/m<sup>2</sup>). The majority of participants presented with established impaired kidney function, as indicated by a median eGFR of 46 mL/min/1.73 m<sup>2</sup>. The age distribution ranged from 25 to 87 years, with a median age of 63 years. The median CKD273 score was 0.57 (95% confidence interval (CI): 0.02, 1.02). The median follow-up time was 1.50 years (interquartile range (IQR): 1.00–2.92). A total of 71 CKD events were recorded during follow-up. The occurrence of CKD events across the cohorts did not show statistically significant differences in incidence rates (<em>p</em> = 0.3), suggesting a comparable risk distribution. Furthermore, no significant differences were observed in other relevant clinical or demographic variables between the cohorts (Supplementary Table 3). The summary clinical and demographic variables are listed in Table <a href="#Tab1" class="usa-link">1</a>, and in Supplementary Table S2 on an individual level.</p>
<section class="tw xbox font-sm" id="Tab1"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Descriptive statistics for the participants providing the urine samples (n = 935) analysed within the study</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Duration of follow-up (years)</th>
<th align="left" colspan="1" rowspan="1">1.50 (0.35, 5.0)</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Clinical characteristics</td>
<td align="left" colspan="1" rowspan="1"></td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Age (years)</td>
<td align="left" colspan="1" rowspan="1">63 (45, 78)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Female, n (%)</td>
<td align="left" colspan="1" rowspan="1">255 (27.3%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SBP (mm Hg)</td>
<td align="left" colspan="1" rowspan="1">138 (109, 160)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">DBP (mm Hg)</td>
<td align="left" colspan="1" rowspan="1">77 (56, 95)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Hypertension, n (%)</td>
<td align="left" colspan="1" rowspan="1">461 (49.4%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Diabetes, n (%)</td>
<td align="left" colspan="1" rowspan="1">914 (97.8%)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">eGFR (mL/min/1.73 m2)</td>
<td align="left" colspan="1" rowspan="1">45.95 (19.57, 113.38)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">BMI (kg/m<sup>2</sup>)</td>
<td align="left" colspan="1" rowspan="1">30.3 (21.7, 44.8)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">CKD273 score</td>
<td align="left" colspan="1" rowspan="1">0.565 (0.02, 1.02)</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p19"><p>Categorical variables are described with absolute (N) and group-wise relative frequencies (%), continuous variables with median (95% CI). BMI body mass index, CI Confidence Interval, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, SBP systolic blood pressure</p></div></div></section></section><section id="Sec9"><h3 class="pmc_sec_title">Event prediction using CKD273 classifier</h3>
<p id="Par27">As a first step the relationship between the peptide-based classifier CKD273 and the risk of MAKE was investigated. The data were categorized into tertiles based on their CKD273 classifier scores, enabling stratification into low, intermediate, and high-risk subgroups. The incidence of MAKE progressively increased across the tertile subgroups. A distinct stepwise rise in risk was observed, with individuals in the highest tertile showing significantly higher event rates compared to those in the lowest tertile (P &lt; 0.0001, hazard ratio 4.26 (95%CI: 2.35–7.73), Supplementary Figure S1). This observation confirms the predictive power of the CKD273 classifier, demonstrating its capacity to effectively differentiate between patients with varying degrees of risk for a kidney event.</p></section><section id="Sec10"><h3 class="pmc_sec_title">Reduction of CKD273 scoring following in silico intervention</h3>
<p id="Par28">The CKD273 score was assessed for patients at baseline and following in silico treatment. Each single intervention and all possible combinations were investigated. In total, this process resulted in the in silico application of 63 different therapeutic regimens. The comprehensive range of simulated treatments allowed for the tentative identification of the most effective intervention tailored to each individual patient's molecular profile.</p>
<p id="Par29">For the in silico -treated subjects, the intervention yielding the lowest CKD273 score was selected as the optimal intervention for maximizing CKD risk reduction. CKD273 scores before and after the in silico interventions are detailed in Supplementary Table S4. Following the predicted most beneficial intervention, there was a reduction in the median CKD273 score from 0.57 (IQR: 0.19–0.81) before treatment to 0.039 (IQR: −0.192–0.363) after treatment (paired Wilcoxon test, <em>P</em> &lt; 0.0001) (Fig. <a href="#Fig3" class="usa-link">3</a>A). There was a clear shift in the distribution of scores toward negative values (Fig. <a href="#Fig3" class="usa-link">3</a>B), indicating a potential reduction of CKD progression. For every subject, at least one intervention or combination of interventions successfully reduced the CKD273 score. The mean decrease in CKD273 score (delta) before and after treatment, based on the lowest score achieved, was 0.45. The analysis revealed that the impact of interventions was significantly associated with the baseline CKD273 score. Patients with higher baseline scores exhibited a greater absolute reduction in CKD273 scores following in silico interventions (rho = −0.355, p &lt; 0.0001), likely reflecting a higher burden of active pathological processes at baseline.</p>
<figure class="fig xbox font-sm" id="Fig3"><h4 class="obj_head">Fig. 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372250_12967_2025_6977_Fig3_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/278b/12372250/b047ad106b8f/12967_2025_6977_Fig3_HTML.jpg" loading="lazy" id="MO3" height="316" width="797" alt="Fig. 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Assessment of CKD273 scores before and after in silico intervention. Box-and-whisker plots (<strong>A</strong>) and scatter plot (<strong>B</strong>) illustrating the distribution of CKD273 scores before and after the in silico intervention. The scatter plot represents CKD273 scores before (as measured in urine of patients) in the vertical axis and CKD273 scores after (as predicted by in silico interventions) in the horizontal axis. Note the different scale of the two axes. For in silico-treated subjects, the intervention that resulted in the lowest CKD273 score was plotted</p></figcaption></figure><p id="Par30">The number of patients benefiting most (based on the largest reduction in CKD273) from a specific intervention (single or combination) is shown in Table <a href="#Tab2" class="usa-link">2</a>. Interestingly, the combination of all available treatments was not the most frequently predicted as optimal intervention (Fig. <a href="#Fig4" class="usa-link">4</a>A). Instead, specific combinations, such as MRA + SGLT2i + ARB, were frequently predicted as optimal interventions compared to single or double interventions. Patients for whom in silico interventions predicted treatment with a higher number of drugs tended to have higher CKD273 scores before treatment (Fig. <a href="#Fig4" class="usa-link">4</a>B). This suggests that individuals with a higher initial risk required more complex combinations of interventions to achieve the maximal reduction in CKD273 scores.</p>
<section class="tw xbox font-sm" id="Tab2"><h4 class="obj_head">Table 2.</h4>
<div class="caption p"><p>Overview of the number of subjects corresponding to each predicted optimal interventions, and the combinations of interventions that resulted in the maximal reduction of risk</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead><tr>
<th align="left" colspan="1" rowspan="1">Intervention</th>
<th align="left" colspan="1" rowspan="1"># of subjects</th>
</tr></thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + GLP1RA + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">320</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + GLP1RA + SGLT2I + Olive oil + ARB</td>
<td align="left" colspan="1" rowspan="1">165</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">123</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">120</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + ARB</td>
<td align="left" colspan="1" rowspan="1">48</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + GLP1RA + ARB</td>
<td align="left" colspan="1" rowspan="1">39</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + GLP1RA + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">31</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + ARB</td>
<td align="left" colspan="1" rowspan="1">16</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + GLP1RA + ARB</td>
<td align="left" colspan="1" rowspan="1">16</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">15</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exercise + GLP1RA + ARB</td>
<td align="left" colspan="1" rowspan="1">8</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">ARB</td>
<td align="left" colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLP1RA + ARB</td>
<td align="left" colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLP1RA + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + GLP1RA + SGLT2I</td>
<td align="left" colspan="1" rowspan="1">4</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exercise + GLP1RA + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLP1RA + SGLT2I</td>
<td align="left" colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Olive oil</td>
<td align="left" colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + SGLT2I + Olive oil + ARB</td>
<td align="left" colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + SGLT2I</td>
<td align="left" colspan="1" rowspan="1">2</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exercise + GLP1RA + SGLT2I + Olive oil + ARB</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Exercise + SGLT2I + ARB</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">GLP1RA</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">SGLT2I</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + GLP1RA + SGLT2I</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + Exercise + SGLT2I</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + GLP1RA + Olive oil + ARB</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">MRA + SGLT2I + Olive oil + ARB</td>
<td align="left" colspan="1" rowspan="1">1</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/Tab2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<div class="tw-foot p"><div class="fn" id="_fn_p26"><p>ARB angiotensin receptor blockers, GLP1RA Glucagon-like peptide-1 receptor agonist, MRA mineralocorticoid receptor antagonist, SGLT2I sodium-glucose co-transporter 2 inhibitor</p></div></div></section><figure class="fig xbox font-sm" id="Fig4"><h4 class="obj_head">Fig. 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372250_12967_2025_6977_Fig4_HTML.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/278b/12372250/24b1dc6f7919/12967_2025_6977_Fig4_HTML.jpg" loading="lazy" id="MO4" height="343" width="768" alt="Fig. 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/Fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>The number of interventions predicted to be applied in combination for the optimal treatment strategy. <strong>A</strong> Pie chart showing the frequency distribution of the predicted optimal number of intervention combinations per patient (<em>n</em> = 935). <strong>B</strong> Plot illustrating the association between the baseline CKD273 score of patients prior to the intervention and the number of interventions predicted to be applied in combination to result in the lowest CKD273 score post-intervention</p></figcaption></figure></section><section id="Sec11"><h3 class="pmc_sec_title">
<em>Reduction in Risk of MAKE following </em>in silico<em> intervention</em>
</h3>
<p id="Par31">The relationship between the estimated time to a 50% risk of MAKE and the baseline CKD273 score for the subjects in the study is displayed in Supplementary Figure S2. The relation was used to develop a predictive model to estimate the time to a 50% risk of MAKE, followed by the incidence rate of MAKE per 100 person-years, based on the CKD273 score. The respective CKD273 scoring and calculations are given in Supplementary Table S4. Based on this transformation, the median incidence rate per 100 person-years risk of MAKE was 4.5 at the baseline and 1.43 after the predicted optimal intervention (Fig. <a href="#Fig5" class="usa-link">5</a>), with a median relative risk reduction of 61% (Supplementary Table S4). Briefly, if a study followed 1,000 people for one year, we would expect about 45 new cases of MAKE without and 14 after the application of the in silico intervention, based on the median incidence rates.</p>
<figure class="fig xbox font-sm" id="Fig5"><h4 class="obj_head">Fig. 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><img class="graphic" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/278b/12372250/8160fbac9207/12967_2025_6977_Fig5_HTML.jpg" loading="lazy" id="MO5" height="438" width="596" alt="Fig. 5"></p>
<div class="p text-right font-secondary"><a href="figure/Fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Box-and-whisker plots illustrate the incidence rate of major adverse kidney events (MAKE) per 100 person-years before and after the in silico intervention. A significant decrease is observed following the application of the in silico intervention (paired Wilcoxon test, <em>P</em> &lt; 0.0001), indicating a reduction in risk after the intervention. Abbreviations: IR- incidence rate, pyers- person years</p></figcaption></figure></section></section><section id="Sec12"><h2 class="pmc_sec_title">Discussion</h2>
<p id="Par32">Prediction of response to intervention has been identified as a key topic in patient management, with proteomics holding the promise of providing solutions [<a href="#CR35" class="usa-link" aria-describedby="CR35">35</a>]. As one first step in this direction, the PRE-score has been introduced by the group of Heerspink and colleagues to predict response to therapy, based on selected clinical variables [<a href="#CR36" class="usa-link" aria-describedby="CR36">36</a>]. The availability of a plethora of different drugs and drug classes has nurtured interest in the concept of multifactorial intervention in CKD in recent years, driven by evidence suggesting that addressing multiple pathways simultaneously can slow progression, reduce complications, and improve quality of life. The 2024 KIDGO guidelines [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. list 4 pharmacological interventions to treat CKD and the list is likely to grow given ongoing clinical trials and additional kidney protective drugs already approved for specific indications, frequently at very high cost. However, the optimal composition and implementation of such interventions remain underexplored.</p>
<p id="Par33">In this study we investigated an alternative approach for the management of CKD, based on molecular signatures. CKD remains a major public health challenge, predicted to become the 5th global cause of death by 2040 [<a href="#CR38" class="usa-link" aria-describedby="CR38">38</a>, <a href="#CR39" class="usa-link" aria-describedby="CR39">39</a>]. This study addresses the urgent need for guidance on personalized interventions for CKD patients. While the benefit is not formally demonstrated in a prospective trial, it could serve as guidance for treatment, which is currently lacking. It additionally may guide the design of future clinical trials [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. The goal is to move away from a “trial-and-error” approach towards a precision medicine model for CKD management, where treatments are not only based on clinical features but are also guided by molecular insights specific to each patient. This is expected to significantly improve patient outcomes by tailoring interventions to the individual's disease profile, optimizing the use of available therapies, and potentially delaying or even preventing the need for kidney replacement therapies such as dialysis. As the field of CKD treatment continues to evolve, personalized strategies based on molecular profiling, such as those derived from the urine peptidome, hold promise to become a cornerstone of clinical practice.</p>
<p id="Par34">The theoretical background, to adjust treatment based on the individual molecular phenotype, is already in place in oncology [<a href="#CR40" class="usa-link" aria-describedby="CR40">40</a>]. Nephrology faces a similar dilemma: while multiple drugs are available, there is lack of sufficient guidance on which one to use and how to effectively combine them [<a href="#CR37" class="usa-link" aria-describedby="CR37">37</a>]. However a genetics-based treatment adjustment strategy as in oncology is not applicable to CKD. As such, it seems reasonable to start an approach in a similar direction: to obtain guidance on the optimal intervention from the patient’s molecular phenotype, however, in this case based on urinary peptide signatures that reflect non-invasively the “status” and (patho)physiology of the kidney [<a href="#CR41" class="usa-link" aria-describedby="CR41">41</a>–<a href="#CR43" class="usa-link" aria-describedby="CR43">43</a>].</p>
<p id="Par35">By developing an in silico treatment profile for each patient, the effects of intended treatments and their combinations can be efficiently simulated based on retrospective proteomic substance-related outcome data. Our approach was based on fold change multiplication to simulate the combined effects of various interventions. This pragmatic method was chosen due to the lack of peptidomics data illustrating the impact of multiple interventions on peptide levels, and for its scalability in simulating numerous interventions in silico.</p>
<p id="Par36">Validated in a prospective trial and supported by the FDA for use in early kidney disease detection during drug development, CKD273 composite score captures the complexity of CKD by integrating multiple molecular markers, which represent different pathological mechanisms of the disease. Unlike single biomarkers, this approach provides a more comprehensive view of CKD. The classifier can distinguish between low- and high-risk individuals and show its utility as a stratification tool for personalized intervention strategies [<a href="#CR15" class="usa-link" aria-describedby="CR15">15</a>]. The ability to simulate the effects of drugs on this composite score, reflecting their influence on multiple molecular pathways, allows for predictions of therapeutic impact, based on molecular changes. The proposed approach provides information on each patient for all combinations of interventions, enabling clinicians to make tailored decisions. Even though specific interventions could be excluded based on patient characteristics, risks, or contraindications, based on all available data the optimal treatment excluding the specific intervention can still be defined. It is important to acknowledge that the underlying peptide shifts used for simulation were derived from real-world interventional trials in which CKD273 was measured before and after treatment. Thus, the molecular changes applied to simulate therapeutic effects are empirically based. However, since these data were used to estimate the predictive framework, they cannot serve as an independent validation. A prospective trial will be required to confirm the predictive utility of this approach.</p>
<p id="Par37">The study has several limitations, in part also owed to its novelty:</p>
<ol class="list" style="list-style-type:decimal">
<li><p id="Par38">The in silico intervention is based on previously collected data, many from moderate size studies. Future investigations of larger cohorts with a longer follow-up time should enable prediction of the drug effect with higher accuracy.</p></li>
<li><p id="Par39">Possible confounders that may impact the drug effects are not known and were therefore not taken into account, neither were albuminuria or background treatment at the time of sampling.</p></li>
<li><p id="Par40">The approach assumes that the treatment effects are independent and additive, due to lack of data on potential interactions between interventions. All interventions were therefore considered independent from each other. This approach may, in some cases, affect the accuracy of the predicted outcomes, thus further validation is planned to address these limitations.</p></li>
<li><p id="Par41">The study is observational, a causal relationship between peptidomic changes and clinical outcomes was not investigated and is not implied.</p></li>
<li><p id="Par42">This is an in silico study, the exact benefit of the approach can only be assessed based on prospective trials, comparing clinical randomized trials with the in silico guided intervention.</p></li>
<li><p id="Par43">The MRA tested in urinary peptidomics was spironolactone, a steroidal MRA while the approved drug to treat CKD is finerenone, a nonsteroidal MRA.</p></li>
<li><p id="Par44">Due to the retrospective nature of the study and limited covariate data, adjustment for potential confounders such as comorbidities, medications, or lifestyle factors was not possible.</p></li>
<li><p id="Par45">Important clinical, lifestyle, genetic, and epigenetic factors influencing CKD progression, such as blood pressure, weight, diet, smoking, and metabolic control, were not assessed due to limited data availability. Their impact should be evaluated in future prospective studies.</p></li>
</ol></section><section id="Sec13"><h2 class="pmc_sec_title">Conclusions</h2>
<p id="Par46">In this study, we demonstrated the feasibility of a robust, pragmatic and effective approach using the individual, molecular peptidomic signature of a patient to guide treatment in CKD. The study was based on the hypothesis that a pharmaco-omics approach, in this case based on urine peptides, should enable guiding a personalized approach towards management of CKD. An apparent major benefit of the approach is that due to the high dimensionality (over 20,000 peptides in urine are described and assessed), the theoretical benefit of not just one, but of combined therapeutic interventions can be predicted. In addition, impact of additional treatments (e.g. novel drugs) can be added to the approach, enabling expansion with moderate efforts. Our data describe a potential profiling tool towards optimisation of CKD treatment. A prospective study is currently being planned to validate the in silico-guided intervention approach and determine its exact benefits on patient-relevant outcomes. This is even more important considering the availability of multiple drug classes for intervention, the lack of guidance selecting the most appropriate compounds and the high costs for novel drugs.</p></section><section id="Sec14"><h2 class="pmc_sec_title">Supplementary Information</h2>
<section class="sm xbox font-sm" id="MOESM1"><div class="media p"><div class="caption">
<a href="/articles/instance/12372250/bin/12967_2025_6977_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Additional file1</a><sup> (674.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="MOESM2"><div class="media p"><div class="caption">
<a href="/articles/instance/12372250/bin/12967_2025_6977_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Additional file2</a><sup> (673.9KB, xlsx) </sup>
</div></div></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgements</h2>
<p>Not applicable.</p></section><section id="glossary1" class="glossary"><h2 class="pmc_sec_title">Abbreviations</h2>
<dl class="def-list">
<dt>ACE</dt>
<dd><p id="Par5">Angiotensin-converting enzyme</p></dd>
<dt>ARB</dt>
<dd><p id="Par6">Angiotensin receptor blocker</p></dd>
<dt>BMI</dt>
<dd><p id="Par7">Body mass index</p></dd>
<dt>CI</dt>
<dd><p id="Par8">Confidence interval</p></dd>
<dt>CKD</dt>
<dd><p id="Par9">Chronic kidney disease</p></dd>
<dt>eGFR</dt>
<dd><p id="Par10">Estimated glomerular filtration rate</p></dd>
<dt>GLP-1 RA</dt>
<dd><p id="Par11">Glucagon-like peptide-1 receptor agonist</p></dd>
<dt>IQR</dt>
<dd><p id="Par12">Interquartile range</p></dd>
<dt>MAKE</dt>
<dd><p id="Par13">Major adverse kidney event</p></dd>
<dt>MRA</dt>
<dd><p id="Par14">Mineralocorticoid receptor antagonist</p></dd>
<dt>SGLT2i</dt>
<dd><p id="Par15">Sodium-glucose co-transporter 2 inhibitor</p></dd>
<dt>SVM</dt>
<dd><p id="Par16">Support vector machine</p></dd>
</dl></section><section id="notes1"><h2 class="pmc_sec_title">Author contributions</h2>
<p>Conceptualization, H.M., J.S., F.K., J.B., A.L.; Methodology, A.L., I.M., T.M.N.N., I.G., F.K., G.M., P.R., J.A.S., C.D., J.B., G.G., A.L.K, J.P.S., A.V., K.P., I.R., A.O., A.C., H.R., F.P., H.M., J.S; formal analysis, A.L., I.M., F.K., T.M.N.N., I.G., H.M., and J.S.; writing—original draft preparation, A.L., I.M., J.S., H.M.; visualization, J.S., I.M., A.L., H.M., T.M.N.N. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This project was supported in part by the German ministry for education and science (BMBF) via UPTAKE (01EK2105A, 01EK2105B, 01EK2105C) to HR, HM, JS, AL and JB. Additional funding was provided by the ERA PerMed SIGNAL project (by BMBF under grant number 01KU2307, by Austrian Science Fund (FWF) under project number I 6464, Grant-DOI10.55776/I6464 and Agence Nationale de le Recherche under grant number ANR-22-PERM-0002–06), Accurate-CVD (ZIMKK5560002AP3) funded by the by the BMWK (Federal Ministry for Economic Affairs and Climate Protection), European Union’s Horizon 2020 research and innovation programme under grant agreement No 848011 for the DC-ren project, and the European Union’s Horizon Europe Marie Skłodowska-Curie Actions Doctoral Networks–Industrial Doctorates Programme DisCo-I (HORIZON–MSCA–2021–DN, 101072828) and PICKED (HORIZON-MSCA-2023-DN, 101168626). AO research is supported by FIS/Fondos FEDER ERA-PerMed-JTC2022 (SPAREKID AC22/00027). Comunidad de Madrid en Biomedicina P2022/BMD-7223. CIFRA_COR-CM. Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001) funded by European Union–NextGenerationEU. Mecanismo para la Recuperación y la Resiliencia (MRR) and SPACKDc PMP21/00109. FEDER funds. The project also received support from the COST Action PERMEDIK CA21165 supported by COST (European Cooperation in Science and Technology) and from the PREVENTCKD Consortium. Project ID: 101101220 Programme: EU4H. DG/Agency: HADEA. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the granting authorities. Neither the European Union nor the granting authority can be held responsible for them.</p></section><section id="notes3"><h2 class="pmc_sec_title">Data availability</h2>
<p>Anonymized data used for the analyses will be made available upon request directed to the corresponding author. Proposals will be reviewed and approved by the authors with based on scientific merit and feasibility. After approval of a proposal, data can be shared via a secure online platform after signing a data access and confidentiality agreement. Data will be made available for a maximum of 5 years after a data sharing agreement has been signed.</p></section><section id="notes4"><h2 class="pmc_sec_title">Declarations</h2>
<section id="FPar1"><h3 class="pmc_sec_title">Ethics approval and consent to participate</h3>
<p id="Par47">The study was conducted according to the guidelines of the Declaration of Helsinki. All datasets were fully anonymized and from previous studies. The ethics committee of the Hannover Medical School Germany waived ethical approval under the reference number 3116–2016 for all studies involving re-use of data from anonymized urine samples.</p></section><section id="FPar2"><h3 class="pmc_sec_title">Consent for publication</h3>
<p id="Par48">Not applicable.</p></section><section id="FPar3"><h3 class="pmc_sec_title">Competing interests</h3>
<p id="Par49">HM is the co-founder and co-owner of Mosaiques Diagnostics (Hannover, Germany). He filed a patent application on the in silico driven treatment prediction model using urinary peptidomics (EP 23734620.0). AL, TMNN, IG, IM and JS are employed by Mosaiques Diagnostics. ALC is member of the BCS Chair Programme Committee. HR has received consulting fees from Otsuka (Advisory Board Sebiprenlimab), Bayer Vital (Advisory Board Herz und Niere) and Stada (Neue Dg und Th Optionen), payment or honoraria from AstraZeneca (Therapien der Zukunft, DGfN), Boehringer (Herz Forum Heidelberg), Pfizer (Kardiologie Hand in Hand im Frankenland), Vifor (ANCA-Vaskulitis) and support for attending meetings and/or travel from Alexion (DGfN) and AstraZeneca (ERA). GG is co-chair of the European Uremic Toxin Workgroup (EUTox) and was supported for attending meetings and/or travel from the COST ACTION PerMediK (CA21165). JPS was supported by the ERA PerMed SIGNAL project (Agence Nationale de le Recherche under grant number ANR-22-PERM-0002–06). AO has received grants from Sanofi (Grants to institution: IIS-FJD UAM) and is Director of the Catedra Astrazeneca-UAM of chronic kidney disease and electrolytes (Grants to Universidad Autonoma de Madrid (UAM)). AO has also received consultancy fees from Astellas, Astrazeneca, Bioporto, Boehringer Ingelheim, Fresenius Medical Care, GSK, Bayer, Sanofi- Genzyme, Lilly, Chiesi, Otsuka, Novo-Nordisk, Sysmex, speaker fees from Astellas, Astrazeneca, Bioporto, Boehringer Ingelheim, Fresenius Medical Care, GSK, Bayer, Sanofi- Genzyme, Sobi, Menarini, Lilly, Chiesi, Otsuka, Novo-Nordisk, Sysmex and Vifor Fresenius Medical Care Renal Pharma and Spafarma, and travel support (Payments to travel agency or hotel for travel/stay) from Astellas, Astrazeneca, Fresenius Medical Care, Boehringer- Ingelheim, Bayer, Sanofi-Genzyme, Chiesi, Sobi, Bayer. He is a member of the Council ERA. SOMANE. PR has received grants (to the institution) by Novo Nordisk, Bayer, Astra Zeneca. He also received honoraria to the institution for education, steering group membership and/or consultancy from Abbott, Bayer, Boehringer Ingelheim, Astra Zeneca, Novo Nordisk, Gilead, Sanofi, Daiichi Sankyo. His institution has also received study drugs from Astra Zeneca, Lexicon, Novo Nordisk, Bayer. Remaining authors have no conflicts of interest to declare.</p></section><section id="FPar4"><h3 class="pmc_sec_title">Generative AI and AI-assisted technologies</h3>
<p id="Par50">During the preparation of this work the author(s) used [ChatGPT by OpenAI, Grammarly]. in order to improve readability and language, including grammar. After using this tool, the author(s) reviewed and edited the content as needed and take(s) full responsibility for the content of the publication.</p></section></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn1">
<p><strong>Publisher's Note</strong></p>
<p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</div></div></section><section id="Bib1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="Bib1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="CR1">
<span class="label">1.</span><cite>Vassalotti JA, Centor R, Turner BJ, Greer RC, Choi M, Sequist TD. Practical approach to detection and management of chronic kidney disease for the primary care clinician. Am J Med. 2016;129:153–62.
</cite> [<a href="https://doi.org/10.1016/j.amjmed.2015.08.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26391748/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Vassalotti%20JA,%20Centor%20R,%20Turner%20BJ,%20Greer%20RC,%20Choi%20M,%20Sequist%20TD.%20Practical%20approach%20to%20detection%20and%20management%20of%20chronic%20kidney%20disease%20for%20the%20primary%20care%20clinician.%20Am%20J%20Med.%202016;129:153%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR2">
<span class="label">2.</span><cite>Wanner C, Inzucchi SE, Lachin JM, Fitchett D, von Eynatten M, Mattheus M, et al. Empagliflozin and progression of kidney disease in type 2 diabetes. N Engl J Med. 2016;375:323–34.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1515920" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27299675/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Wanner%20C,%20Inzucchi%20SE,%20Lachin%20JM,%20Fitchett%20D,%20von%20Eynatten%20M,%20Mattheus%20M,%20et%20al.%20Empagliflozin%20and%20progression%20of%20kidney%20disease%20in%20type%202%20diabetes.%20N%20Engl%20J%20Med.%202016;375:323%E2%80%9334." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR3">
<span class="label">3.</span><cite>Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, et al. Canagliflozin and cardiovascular and renal events in type 2 diabetes. N Engl J Med. 2017;377:644–57.
</cite> [<a href="https://doi.org/10.1056/NEJMoa1611925" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28605608/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Neal%20B,%20Perkovic%20V,%20Mahaffey%20KW,%20de%20Zeeuw%20D,%20Fulcher%20G,%20Erondu%20N,%20et%20al.%20Canagliflozin%20and%20cardiovascular%20and%20renal%20events%20in%20type%202%20diabetes.%20N%20Engl%20J%20Med.%202017;377:644%E2%80%9357." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR4">
<span class="label">4.</span><cite>Dharia A, Khan A, Sridhar VS, Cherney DZI. SGLT2 inhibitors: the sweet success for kidneys. Annu Rev Med. 2023;74:369–84.
</cite> [<a href="https://doi.org/10.1146/annurev-med-042921-102135" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36706745/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dharia%20A,%20Khan%20A,%20Sridhar%20VS,%20Cherney%20DZI.%20SGLT2%20inhibitors:%20the%20sweet%20success%20for%20kidneys.%20Annu%20Rev%20Med.%202023;74:369%E2%80%9384." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR5">
<span class="label">5.</span><cite>Bailey CJ, Day C, Bellary S. Renal protection with SGLT2 inhibitors: effects in acute and chronic kidney disease. Curr Diab Rep. 2022;22:39–52.
</cite> [<a href="https://doi.org/10.1007/s11892-021-01442-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8888485/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35113333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bailey%20CJ,%20Day%20C,%20Bellary%20S.%20Renal%20protection%20with%20SGLT2%20inhibitors:%20effects%20in%20acute%20and%20chronic%20kidney%20disease.%20Curr%20Diab%20Rep.%202022;22:39%E2%80%9352." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR6">
<span class="label">6.</span><cite>Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med. 2020;383:2219–29.
</cite> [<a href="https://doi.org/10.1056/NEJMoa2025845" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33264825/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Bakris%20GL,%20Agarwal%20R,%20Anker%20SD,%20Pitt%20B,%20Ruilope%20LM,%20Rossing%20P,%20et%20al.%20Effect%20of%20finerenone%20on%20chronic%20kidney%20disease%20outcomes%20in%20type%202%20diabetes.%20N%20Engl%20J%20Med.%202020;383:2219%E2%80%9329." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR7">
<span class="label">7.</span><cite>Kolkhof P, Lawatscheck R, Filippatos G, Bakris GL. Nonsteroidal mineralocorticoid receptor antagonism by finerenone-translational aspects and clinical perspectives across multiple organ systems. Int J Mol Sci. 2022;23: 9243.
</cite> [<a href="https://doi.org/10.3390/ijms23169243" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9408839/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36012508/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kolkhof%20P,%20Lawatscheck%20R,%20Filippatos%20G,%20Bakris%20GL.%20Nonsteroidal%20mineralocorticoid%20receptor%20antagonism%20by%20finerenone-translational%20aspects%20and%20clinical%20perspectives%20across%20multiple%20organ%20systems.%20Int%20J%20Mol%20Sci.%202022;23:%209243." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR8">
<span class="label">8.</span><cite>Mann JFE, Rossing P, Bakris G, Belmar N, Bosch-Traberg H, Busch R, et al. Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial. Nat Med. 2024;30:2849–56.
</cite> [<a href="https://doi.org/10.1038/s41591-024-03133-0" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11485243/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38914124/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mann%20JFE,%20Rossing%20P,%20Bakris%20G,%20Belmar%20N,%20Bosch-Traberg%20H,%20Busch%20R,%20et%20al.%20Effects%20of%20semaglutide%20with%20and%20without%20concomitant%20SGLT2%20inhibitor%20use%20in%20participants%20with%20type%202%20diabetes%20and%20chronic%20kidney%20disease%20in%20the%20FLOW%20trial.%20Nat%20Med.%202024;30:2849%E2%80%9356." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR9">
<span class="label">9.</span><cite>Smeijer JD, Kohan DE, Dhaun N, Noronha IL, Liew A, Heerspink HJL. Endothelin receptor antagonists in chronic kidney disease. Nat Rev Nephrol. 2025;21:175–88.
</cite> [<a href="https://doi.org/10.1038/s41581-024-00908-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/39643698/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Smeijer%20JD,%20Kohan%20DE,%20Dhaun%20N,%20Noronha%20IL,%20Liew%20A,%20Heerspink%20HJL.%20Endothelin%20receptor%20antagonists%20in%20chronic%20kidney%20disease.%20Nat%20Rev%20Nephrol.%202025;21:175%E2%80%9388." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR10">
<span class="label">10.</span><cite>Kalantar-Zadeh K, Joshi S, Schlueter R, Cooke J, Brown-Tortorici A, Donnelly M, et al. Plant-dominant low-protein diet for conservative management of chronic kidney disease. Nutrients. 2020;12:29–1931.</cite> [<a href="https://doi.org/10.3390/nu12071931" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7400005/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32610641/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Kalantar-Zadeh%20K,%20Joshi%20S,%20Schlueter%20R,%20Cooke%20J,%20Brown-Tortorici%20A,%20Donnelly%20M,%20et%20al.%20Plant-dominant%20low-protein%20diet%20for%20conservative%20management%20of%20chronic%20kidney%20disease.%20Nutrients.%202020;12:29%E2%80%931931." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR11">
<span class="label">11.</span><cite>Schrauben SJ, Apple BJ, Chang AR. Modifiable lifestyle behaviors and CKD progression: a narrative review. Kidney360. 2022;3:752–78.
</cite> [<a href="https://doi.org/10.34067/KID.0003122021" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9136893/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35721622/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schrauben%20SJ,%20Apple%20BJ,%20Chang%20AR.%20Modifiable%20lifestyle%20behaviors%20and%20CKD%20progression:%20a%20narrative%20review.%20Kidney360.%202022;3:752%E2%80%9378." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR12">
<span class="label">12.</span><cite>Tsimberidou AM, Fountzilas E, Nikanjam M, Kurzrock R. Review of precision cancer medicine: evolution of the treatment paradigm. Cancer Treat Rev. 2020;86: 102019.
</cite> [<a href="https://doi.org/10.1016/j.ctrv.2020.102019" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7272286/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32251926/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tsimberidou%20AM,%20Fountzilas%20E,%20Nikanjam%20M,%20Kurzrock%20R.%20Review%20of%20precision%20cancer%20medicine:%20evolution%20of%20the%20treatment%20paradigm.%20Cancer%20Treat%20Rev.%202020;86:%20102019." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR13">
<span class="label">13.</span><cite>G-BA: <a href="https://www.g-ba.de/downloads/92-975-7848/2024_07_31_Modul3A_Sparsentan.pdf" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.g-ba.de/downloads/92-975-7848/2024_07_31_Modul3A_Sparsentan.pdf</a> 2025.</cite>
</li>
<li id="CR14">
<span class="label">14.</span><cite>Good DM, Zürbig P, Argiles A, Bauer HW, Behrens G, Coon JJ, et al. Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics. 2010;9:2424–37.
</cite> [<a href="https://doi.org/10.1074/mcp.M110.001917" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2984241/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20616184/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Good%20DM,%20Z%C3%BCrbig%20P,%20Argiles%20A,%20Bauer%20HW,%20Behrens%20G,%20Coon%20JJ,%20et%20al.%20Naturally%20occurring%20human%20urinary%20peptides%20for%20use%20in%20diagnosis%20of%20chronic%20kidney%20disease.%20Mol%20Cell%20Proteomics.%202010;9:2424%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR15">
<span class="label">15.</span><cite>Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, et al. Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial. Lancet Diabetes Endocrinol. 2020;8:301–12.
</cite> [<a href="https://doi.org/10.1016/S2213-8587(20)30026-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32135136/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Tofte%20N,%20Lindhardt%20M,%20Adamova%20K,%20Bakker%20SJL,%20Beige%20J,%20Beulens%20JWJ,%20et%20al.%20Early%20detection%20of%20diabetic%20kidney%20disease%20by%20urinary%20proteomics%20and%20subsequent%20intervention%20with%20spironolactone%20to%20delay%20progression%20(PRIORITY):%20a%20prospective%20observational%20study%20and%20embedded%20randomised%20placebo-controlled%20trial.%20Lancet%20Diabetes%20Endocrinol.%202020;8:301%E2%80%9312." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR16">
<span class="label">16.</span><cite>Curovic RV, Eickhoff MK, Ronkko T, Frimodt-Moller M, Hansen TW, Mischak H, et al. Dapagliflozin improves the urinary proteomic kidney-risk classifier CKD273 in type 2 diabetes with albuminuria - a randomized clinical trial. Diabetes Care. 2022;45:2662–8.
</cite> [<a href="https://doi.org/10.2337/dc22-1157" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/35998283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Curovic%20RV,%20Eickhoff%20MK,%20Ronkko%20T,%20Frimodt-Moller%20M,%20Hansen%20TW,%20Mischak%20H,%20et%20al.%20Dapagliflozin%20improves%20the%20urinary%20proteomic%20kidney-risk%20classifier%20CKD273%20in%20type%202%20diabetes%20with%20albuminuria%20-%20a%20randomized%20clinical%20trial.%20Diabetes%20Care.%202022;45:2662%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR17">
<span class="label">17.</span><cite>Lohia S, Siwy J, Mavrogeorgis E, Eder S, Thoni S, Mayer G, et al. Exploratory study analyzing the urinary peptidome of T2DM patients suggests changes in ECM but also inflammatory and metabolic pathways following GLP-1R agonist treatment. Int J Mol Sci. 2023;24: 13540.
</cite> [<a href="https://doi.org/10.3390/ijms241713540" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10488289/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37686344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lohia%20S,%20Siwy%20J,%20Mavrogeorgis%20E,%20Eder%20S,%20Thoni%20S,%20Mayer%20G,%20et%20al.%20Exploratory%20study%20analyzing%20the%20urinary%20peptidome%20of%20T2DM%20patients%20suggests%20changes%20in%20ECM%20but%20also%20inflammatory%20and%20metabolic%20pathways%20following%20GLP-1R%20agonist%20treatment.%20Int%20J%20Mol%20Sci.%202023;24:%2013540." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR18">
<span class="label">18.</span><cite>Jaimes Campos MA, Mavrogeorgis E, Latosinska A, Eder S, Buchwinkler L, Mischak H, et al. Urinary peptide analysis to predict the response to blood pressure medication. Nephrol Dial Transplant. 2024;39:873–83.
</cite> [<a href="https://doi.org/10.1093/ndt/gfad223" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11181870/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37930730/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jaimes%20Campos%20MA,%20Mavrogeorgis%20E,%20Latosinska%20A,%20Eder%20S,%20Buchwinkler%20L,%20Mischak%20H,%20et%20al.%20Urinary%20peptide%20analysis%20to%20predict%20the%20response%20to%20blood%20pressure%20medication.%20Nephrol%20Dial%20Transplant.%202024;39:873%E2%80%9383." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR19">
<span class="label">19.</span><cite>Silva S, Bronze MR, Figueira ME, Siwy J, Mischak H, Combet E, et al. Impact of a 6-wk olive oil supplementation in healthy adults on urinary proteomic biomarkers of coronary artery disease, chronic kidney disease, and diabetes (types 1 and 2): a randomized, parallel, controlled, double-blind study. Am J Clin Nutr. 2015;101:44–54.
</cite> [<a href="https://doi.org/10.3945/ajcn.114.094219" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25527749/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Silva%20S,%20Bronze%20MR,%20Figueira%20ME,%20Siwy%20J,%20Mischak%20H,%20Combet%20E,%20et%20al.%20Impact%20of%20a%206-wk%20olive%20oil%20supplementation%20in%20healthy%20adults%20on%20urinary%20proteomic%20biomarkers%20of%20coronary%20artery%20disease,%20chronic%20kidney%20disease,%20and%20diabetes%20(types%201%20and%202):%20a%20randomized,%20parallel,%20controlled,%20double-blind%20study.%20Am%20J%20Clin%20Nutr.%202015;101:44%E2%80%9354." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR20">
<span class="label">20.</span><cite>Andersen S, Mischak H, Zürbig P, Parving HH, Rossing P. Urinary proteome analysis enables assessment of renoprotective treatment in type 2 diabetic patients with microalbuminuria. BMC Nephrol. 2010;11:29.
</cite> [<a href="https://doi.org/10.1186/1471-2369-11-29" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2988775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21040538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Andersen%20S,%20Mischak%20H,%20Z%C3%BCrbig%20P,%20Parving%20HH,%20Rossing%20P.%20Urinary%20proteome%20analysis%20enables%20assessment%20of%20renoprotective%20treatment%20in%20type%202%20diabetic%20patients%20with%20microalbuminuria.%20BMC%20Nephrol.%202010;11:29." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR21">
<span class="label">21.</span><cite>Jaimes Campos MA, Andujar I, Keller F, Mayer G, Rossing P, Staessen JA, et al. Prognosis and personalized in silico prediction of treatment efficacy in cardiovascular and chronic kidney disease: a proof-of-concept study. Pharmaceuticals (Basel). 2023;16: 1298.
</cite> [<a href="https://doi.org/10.3390/ph16091298" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10537115/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37765106/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jaimes%20Campos%20MA,%20Andujar%20I,%20Keller%20F,%20Mayer%20G,%20Rossing%20P,%20Staessen%20JA,%20et%20al.%20Prognosis%20and%20personalized%20in%20silico%20prediction%20of%20treatment%20efficacy%20in%20cardiovascular%20and%20chronic%20kidney%20disease:%20a%20proof-of-concept%20study.%20Pharmaceuticals%20(Basel).%202023;16:%201298." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR22">
<span class="label">22.</span><cite>Keller F, Beige J, Siwy J, Mebazaa A, An D, Mischak H, et al. Urinary peptides provide information about the risk of mortality across a spectrum of diseases and scenarios. J Transl Med. 2023;21:663.
</cite> [<a href="https://doi.org/10.1186/s12967-023-04508-6" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10518109/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37741989/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Keller%20F,%20Beige%20J,%20Siwy%20J,%20Mebazaa%20A,%20An%20D,%20Mischak%20H,%20et%20al.%20Urinary%20peptides%20provide%20information%20about%20the%20risk%20of%20mortality%20across%20a%20spectrum%20of%20diseases%20and%20scenarios.%20J%20Transl%20Med.%202023;21:663." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR23">
<span class="label">23.</span><cite>Staessen JA, Wendt R, Yu YL, Kalbitz S, Thijs L, Siwy J, et al. Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study. Lancet Digit Health. 2022;10:e727–37.</cite> [<a href="https://doi.org/10.1016/S2589-7500(22)00150-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9432869/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36057526/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Staessen%20JA,%20Wendt%20R,%20Yu%20YL,%20Kalbitz%20S,%20Thijs%20L,%20Siwy%20J,%20et%20al.%20Predictive%20performance%20and%20clinical%20application%20of%20COV50,%20a%20urinary%20proteomic%20biomarker%20in%20early%20COVID-19%20infection:%20a%20prospective%20multicentre%20cohort%20study.%20Lancet%20Digit%20Health.%202022;10:e727%E2%80%9337." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR24">
<span class="label">24.</span><cite>Jantos-Siwy J, Schiffer E, Brand K, Schumann G, Rossing K, Delles C, et al. Quantitative urinary proteome analysis for biomarker evaluation in chronic kidney disease. J Proteome Res. 2009;8:268–81.
</cite> [<a href="https://doi.org/10.1021/pr800401m" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19012428/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Jantos-Siwy%20J,%20Schiffer%20E,%20Brand%20K,%20Schumann%20G,%20Rossing%20K,%20Delles%20C,%20et%20al.%20Quantitative%20urinary%20proteome%20analysis%20for%20biomarker%20evaluation%20in%20chronic%20kidney%20disease.%20J%20Proteome%20Res.%202009;8:268%E2%80%9381." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR25">
<span class="label">25.</span><cite>Gonidaki C, Vlahou A, Stroggilos R, Mischak H, Latosinska A. Comparative evaluation of imputation and batch-effect correction for proteomics/peptidomicsdifferential-expression analysis. medRxiv. 10.1101/2025.08.14.25333694</cite>
</li>
<li id="CR26">
<span class="label">26.</span><cite>Gregorich M, Kammer M, Mischak H, Heinze G. Prediction modeling with many correlated and zero-inflated predictors: assessing the nonnegative garrote approach. Stat Med. 2025;44: e70062.
</cite> [<a href="https://doi.org/10.1002/sim.70062" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC12023833/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/40277373/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Gregorich%20M,%20Kammer%20M,%20Mischak%20H,%20Heinze%20G.%20Prediction%20modeling%20with%20many%20correlated%20and%20zero-inflated%20predictors:%20assessing%20the%20nonnegative%20garrote%20approach.%20Stat%20Med.%202025;44:%20e70062." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR27">
<span class="label">27.</span><cite>Dakna M, Harris K, Kalousis A, Carpentier S, Kolch W, Schanstra JP, et al. Addressing the challenge of defining valid proteomic biomarkers and classifiers. BMC Bioinformatics. 2010;11:594.
</cite> [<a href="https://doi.org/10.1186/1471-2105-11-594" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3017845/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21208396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Dakna%20M,%20Harris%20K,%20Kalousis%20A,%20Carpentier%20S,%20Kolch%20W,%20Schanstra%20JP,%20et%20al.%20Addressing%20the%20challenge%20of%20defining%20valid%20proteomic%20biomarkers%20and%20classifiers.%20BMC%20Bioinformatics.%202010;11:594." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR28">
<span class="label">28.</span><cite>Lindhardt M, Persson F, Zuerbig P, Stalmach A, Mischak H, de Zeeuw D, et al. Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study. Nephrol Dial Transplant. 2017;32:1866–73.
</cite> [<a href="https://doi.org/10.1093/ndt/gfw292" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27507891/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lindhardt%20M,%20Persson%20F,%20Zuerbig%20P,%20Stalmach%20A,%20Mischak%20H,%20de%20Zeeuw%20D,%20et%20al.%20Urinary%20proteomics%20predict%20onset%20of%20microalbuminuria%20in%20normoalbuminuric%20type%202%20diabetic%20patients,%20a%20sub-study%20of%20the%20DIRECT-Protect%202%20study.%20Nephrol%20Dial%20Transplant.%202017;32:1866%E2%80%9373." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR29">
<span class="label">29.</span><cite>Snell-Bergeon JK, Maahs DM, Ogden LG, Kinney GL, Hokanson JE, Schiffer E, et al. Evaluation of urinary biomarkers for coronary artery disease, diabetes, and diabetic kidney disease. Diabetes Technol Ther. 2009;11:1–9.
</cite> [<a href="https://doi.org/10.1089/dia.2008.0040" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2939844/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19132849/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Snell-Bergeon%20JK,%20Maahs%20DM,%20Ogden%20LG,%20Kinney%20GL,%20Hokanson%20JE,%20Schiffer%20E,%20et%20al.%20Evaluation%20of%20urinary%20biomarkers%20for%20coronary%20artery%20disease,%20diabetes,%20and%20diabetic%20kidney%20disease.%20Diabetes%20Technol%20Ther.%202009;11:1%E2%80%939." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR30">
<span class="label">30.</span><cite>Alkhalaf A, Zürbig P, Bakker SJ, Bilo HJ, Cerna M, Fischer C, et al. Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy. PLoS ONE. 2010;5: e13421.
</cite> [<a href="https://doi.org/10.1371/journal.pone.0013421" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2958112/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20975990/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Alkhalaf%20A,%20Z%C3%BCrbig%20P,%20Bakker%20SJ,%20Bilo%20HJ,%20Cerna%20M,%20Fischer%20C,%20et%20al.%20Multicentric%20validation%20of%20proteomic%20biomarkers%20in%20urine%20specific%20for%20diabetic%20nephropathy.%20PLoS%20ONE.%202010;5:%20e13421." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR31">
<span class="label">31.</span><cite>Verbeke F, Siwy J, Van BW, Mischak H, Pletinck A, Schepers E, et al. The urinary proteomics classifier chronic kidney disease 273 predicts cardiovascular outcome in patients with chronic kidney disease. Nephrol Dial Transplant. 2021;36:811–8.
</cite> [<a href="https://doi.org/10.1093/ndt/gfz242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31837226/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Verbeke%20F,%20Siwy%20J,%20Van%20BW,%20Mischak%20H,%20Pletinck%20A,%20Schepers%20E,%20et%20al.%20The%20urinary%20proteomics%20classifier%20chronic%20kidney%20disease%20273%20predicts%20cardiovascular%20outcome%20in%20patients%20with%20chronic%20kidney%20disease.%20Nephrol%20Dial%20Transplant.%202021;36:811%E2%80%938." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR32">
<span class="label">32.</span><cite>Mischak H, Vlahou A, Ioannidis JP. Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience. Clin Biochem. 2013;46:432–43.
</cite> [<a href="https://doi.org/10.1016/j.clinbiochem.2012.09.025" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23041249/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mischak%20H,%20Vlahou%20A,%20Ioannidis%20JP.%20Technical%20aspects%20and%20inter-laboratory%20variability%20in%20native%20peptide%20profiling:%20the%20CE-MS%20experience.%20Clin%20Biochem.%202013;46:432%E2%80%9343." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR33">
<span class="label">33.</span><cite>Yu YL, Siwy J, An DW, Gonzalez A, Hansen T, Latosinska A, et al. Urinary proteomic signature of mineralocorticoid receptor antagonism by spironolactone: evidence from the HOMAGE trial. Heart. 2024;110:1180–7.
</cite> [<a href="https://doi.org/10.1136/heartjnl-2023-323796" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11420742/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38729636/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Yu%20YL,%20Siwy%20J,%20An%20DW,%20Gonzalez%20A,%20Hansen%20T,%20Latosinska%20A,%20et%20al.%20Urinary%20proteomic%20signature%20of%20mineralocorticoid%20receptor%20antagonism%20by%20spironolactone:%20evidence%20from%20the%20HOMAGE%20trial.%20Heart.%202024;110:1180%E2%80%937." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR34">
<span class="label">34.</span><cite>Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–60.
</cite> [<a href="https://doi.org/10.1056/NEJMoa011303" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11565517/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Lewis%20EJ,%20Hunsicker%20LG,%20Clarke%20WR,%20Berl%20T,%20Pohl%20MA,%20Lewis%20JB,%20et%20al.%20Renoprotective%20effect%20of%20the%20angiotensin-receptor%20antagonist%20irbesartan%20in%20patients%20with%20nephropathy%20due%20to%20type%202%20diabetes.%20N%20Engl%20J%20Med.%202001;345:851%E2%80%9360." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR35">
<span class="label">35.</span><cite>Pena MJ, Mischak H, Heerspink HJ. Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease. Diabetologia. 2016;59:1819–31.
</cite> [<a href="https://doi.org/10.1007/s00125-016-4001-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4969331/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27344310/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Pena%20MJ,%20Mischak%20H,%20Heerspink%20HJ.%20Proteomics%20for%20prediction%20of%20disease%20progression%20and%20response%20to%20therapy%20in%20diabetic%20kidney%20disease.%20Diabetologia.%202016;59:1819%E2%80%9331." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR36">
<span class="label">36.</span><cite>Schievink B, de Zeeuw D, Smink PA, Andress D, Brennan JJ, Coll B, et al. Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers. Eur J Prev Cardiol. 2016;23:758–68.
</cite> [<a href="https://doi.org/10.1177/2047487315598709" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7735387/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26229089/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Schievink%20B,%20de%20Zeeuw%20D,%20Smink%20PA,%20Andress%20D,%20Brennan%20JJ,%20Coll%20B,%20et%20al.%20Prediction%20of%20the%20effect%20of%20atrasentan%20on%20renal%20and%20heart%20failure%20outcomes%20based%20on%20short-term%20changes%20in%20multiple%20risk%20markers.%20Eur%20J%20Prev%20Cardiol.%202016;23:758%E2%80%9368." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR37">
<span class="label">37.</span><cite>KDIGO. Clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2024;2024(105):S117–314.</cite> [<a href="https://doi.org/10.1016/j.kint.2023.10.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38490803/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?KDIGO.%20Clinical%20practice%20guideline%20for%20the%20evaluation%20and%20management%20of%20chronic%20kidney%20disease.%20Kidney%20Int.%202024;2024(105):S117%E2%80%93314." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR38">
<span class="label">38.</span><cite>Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, McGaughey M, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392:2052–90.
</cite> [<a href="https://doi.org/10.1016/S0140-6736(18)31694-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6227505/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30340847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Foreman%20KJ,%20Marquez%20N,%20Dolgert%20A,%20Fukutaki%20K,%20Fullman%20N,%20McGaughey%20M,%20et%20al.%20Forecasting%20life%20expectancy,%20years%20of%20life%20lost,%20and%20all-cause%20and%20cause-specific%20mortality%20for%20250%20causes%20of%20death:%20reference%20and%20alternative%20scenarios%20for%202016%E2%80%9340%20for%20195%20countries%20and%20territories.%20Lancet.%202018;392:2052%E2%80%9390." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR39">
<span class="label">39.</span><cite>Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021<strong>.</strong> Lancet 2024; 403<strong>:</strong>2204–2256.</cite> [<a href="https://doi.org/10.1016/S0140-6736(24)00685-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC11121021/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38762325/" class="usa-link">PubMed</a>]</li>
<li id="CR40">
<span class="label">40.</span><cite>Hoeben A, Joosten EAJ, van Beuken-Everdingen MHJ. Personalized medicine: recent progress in cancer therapy. Cancers (Basel). 2021;13:242.
</cite> [<a href="https://doi.org/10.3390/cancers13020242" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7826530/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33440729/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Hoeben%20A,%20Joosten%20EAJ,%20van%20Beuken-Everdingen%20MHJ.%20Personalized%20medicine:%20recent%20progress%20in%20cancer%20therapy.%20Cancers%20(Basel).%202021;13:242." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR41">
<span class="label">41.</span><cite>Mavrogeorgis E, He T, Mischak H, Latosinska A, Vlahou A, Schanstra JP, et al. Urinary peptidomic liquid biopsy for non-invasive differential diagnosis of chronic kidney disease. Nephrol Dial Transplant. 2024;39:453–62.
</cite> [<a href="https://doi.org/10.1093/ndt/gfad200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10899775/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37697716/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Mavrogeorgis%20E,%20He%20T,%20Mischak%20H,%20Latosinska%20A,%20Vlahou%20A,%20Schanstra%20JP,%20et%20al.%20Urinary%20peptidomic%20liquid%20biopsy%20for%20non-invasive%20differential%20diagnosis%20of%20chronic%20kidney%20disease.%20Nephrol%20Dial%20Transplant.%202024;39:453%E2%80%9362." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR42">
<span class="label">42.</span><cite>Catanese L, Rupprecht H, Huber TB, Lindenmeyer MT, Hengel FE, Amann K, et al. Non-invasive biomarkers for diagnosis, risk prediction, and therapy guidance of glomerular kidney diseases: a comprehensive review. Int J Mol Sci. 2024;25: 3519.
</cite> [<a href="https://doi.org/10.3390/ijms25063519" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10970781/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/38542491/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Catanese%20L,%20Rupprecht%20H,%20Huber%20TB,%20Lindenmeyer%20MT,%20Hengel%20FE,%20Amann%20K,%20et%20al.%20Non-invasive%20biomarkers%20for%20diagnosis,%20risk%20prediction,%20and%20therapy%20guidance%20of%20glomerular%20kidney%20diseases:%20a%20comprehensive%20review.%20Int%20J%20Mol%20Sci.%202024;25:%203519." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="CR43">
<span class="label">43.</span><cite>Catanese L, Siwy J, Mavrogeorgis E, Amann K, Mischak H, Beige J, et al. A novel urinary proteomics classifier for non-invasive evaluation of interstitial fibrosis and tubular atrophy in chronic kidney disease. Proteomes. 2021;9:32.
</cite> [<a href="https://doi.org/10.3390/proteomes9030032" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8293473/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34287333/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?Catanese%20L,%20Siwy%20J,%20Mavrogeorgis%20E,%20Amann%20K,%20Mischak%20H,%20Beige%20J,%20et%20al.%20A%20novel%20urinary%20proteomics%20classifier%20for%20non-invasive%20evaluation%20of%20interstitial%20fibrosis%20and%20tubular%20atrophy%20in%20chronic%20kidney%20disease.%20Proteomes.%202021;9:32." class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372250/bin/12967_2025_6977_MOESM1_ESM.pdf" data-ga-action="click_feat_suppl" class="usa-link">Additional file1</a><sup> (674.7KB, pdf) </sup>
</div></div></section><section class="sm xbox font-sm" id="db_ds_supplementary-material2_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372250/bin/12967_2025_6977_MOESM2_ESM.xlsx" data-ga-action="click_feat_suppl" class="usa-link">Additional file2</a><sup> (673.9KB, xlsx) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Anonymized data used for the analyses will be made available upon request directed to the corresponding author. Proposals will be reviewed and approved by the authors with based on scientific merit and feasibility. After approval of a proposal, data can be shared via a secure online platform after signing a data access and confidentiality agreement. Data will be made available for a maximum of 5 years after a data sharing agreement has been signed.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Journal of Translational Medicine are provided here courtesy of <strong>BMC</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1186/s12967-025-06977-3"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/12967_2025_Article_6977.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.0 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372250/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372250/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372250%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372250/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372250/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372250/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40842026/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372250/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40842026/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372250/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372250/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="9MAvoREkYb1q6NEmc2zfIYVo4ZTU9r4weSOS2HdRb9qhxKEeokr7X5M6nHkJOtFS">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
